Marc W. Fariss

4.0k total citations · 1 hit paper
59 papers, 3.5k citations indexed

About

Marc W. Fariss is a scholar working on Molecular Biology, Biochemistry and Nutrition and Dietetics. According to data from OpenAlex, Marc W. Fariss has authored 59 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Biochemistry and 15 papers in Nutrition and Dietetics. Recurrent topics in Marc W. Fariss's work include Antioxidant Activity and Oxidative Stress (21 papers), Vitamin C and Antioxidants Research (15 papers) and Free Radicals and Antioxidants (9 papers). Marc W. Fariss is often cited by papers focused on Antioxidant Activity and Oxidative Stress (21 papers), Vitamin C and Antioxidants Research (15 papers) and Free Radicals and Antioxidants (9 papers). Marc W. Fariss collaborates with scholars based in United States, Australia and Malaysia. Marc W. Fariss's co-authors include Donald J. Reed, Mark A. Tirmenstein, George Zhang, Gary A. Pascoe, Robert V. Blanke, Philip S. Guzelian, Virgil R. Mumaw, Sidhartha D. Ray, Kristín Ólafsdóttir and Ravindra R. Raje and has published in prestigious journals such as Science, New England Journal of Medicine and Hepatology.

In The Last Decade

Marc W. Fariss

59 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-performance liquid chromatography of thiols and disulfides: Dinitrophenol derivatives

1987 484 citations Marc W. Fariss, Donald J. Reed Methods in enzymology on CD-ROM/Methods in enzymology profile →

Peers

Countries citing papers authored by Marc W. Fariss

Since Specialization

Citations

This map shows the geographic impact of Marc W. Fariss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc W. Fariss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc W. Fariss more than expected).

Fields of papers citing papers by Marc W. Fariss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc W. Fariss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc W. Fariss. The network helps show where Marc W. Fariss may publish in the future.

Co-authorship network of co-authors of Marc W. Fariss

This figure shows the co-authorship network connecting the top 25 collaborators of Marc W. Fariss. A scholar is included among the top collaborators of Marc W. Fariss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc W. Fariss. Marc W. Fariss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A systematic review of possible serious adverse health effects of nicotine replacement therapy 2016 ·Archives of Toxicology ·Peter Lee, Marc W. Fariss	37
2	Reference moist smokeless tobacco-induced apoptosis in human monocytes/macrophages cell line MM6 2010 ·International Immunopharmacology ·Catherine Lombard, Don Farthing, Jingping Sun, Marc W. Fariss, Robert J. McKallip	15
3	Role of oxidative stress and MAPK signaling in reference moist smokeless tobacco-induced HOK-16B cell death 2010 ·Toxicology Letters ·Clint Mitchell, Andrew R. Joyce, John T. Piper, Robert J. McKallip, Marc W. Fariss	26
4	Vitamin E Succinate Enhances Steatotic Liver Energy Status and Prevents Oxidative Damage Following Ischemia/Reperfusion 2009 ·Transplantation Proceedings ·Zachary Evans, Bhaskar S. Mandavilli, Justin D. Ellett, (unknown), Marc W. Fariss, Ryan N. Fiorini, Rick G. Schnellmann, Michael G. Schmidt, Kenneth D. Chavin	26
5	Vitamin E Succinate Reduces Ischemia/Reperfusion Injury in Steatotic Livers 2008 ·Transplantation Proceedings ·Zachary Evans, Justin D. Ellett, Marc W. Fariss, Rick G. Schnellmann, Michael G. Schmidt, Kenneth D. Chavin	12
6	ROLE of MITOCHONDRIA in TOXIC OXIDATIVE STRESS 2005 ·Molecular Interventions ·Marc W. Fariss	226
7	Dietary Vitamin E Decreases Doxorubicin- Induced Oxidative Stress Without Preventing Mitochondrial Dysfunction 2005 ·Cardiovascular Toxicology ·Jessica M. Berthiaume, Paulo J. Oliveira, Marc W. Fariss, Kendall B. Wallace	80
8	Vitamin E therapy in Parkinson's disease 2003 ·Toxicology ·Marc W. Fariss	73
9	Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. 2002 ·PubMed ·Tobias Weber, Min Lu, Ladislav Anděra, Harald Lahm, Nina Gellert, Marc W. Fariss, Vladimír Kořínek, Wolfgang Sattler, David S. Ucker, Alexei Terman, Andreas Schröder, Wolfgang Erl, Ulf T. Brunk, Robert J. Coffey, Christian Weber, Jiřı́ Neužil	164
10	Thenoyltrifluoroacetone, a potent inhibitor of carboxylesterase activity 2002 ·Biochemical Pharmacology ·George Zhang, Marc W. Fariss	27
11	Mitochondrial Electron Transport Inhibitors Cause Lipid Peroxidation-Dependent and -Independent Cell Death: Protective Role of Antioxidants 2001 ·Archives of Biochemistry and Biophysics ·George Zhang, Mark A. Tirmenstein, (unknown), Marc W. Fariss	63
12	Vitamin E succinate protects hepatocytes against the toxic effect of reactive oxygen species generated at mitochondrial complexes I and III by alkylating agents 2001 ·Chemico-Biological Interactions ·George Zhang, (unknown), Mark A. Tirmenstein, Marc W. Fariss	65
13	Glutathione depletion and the production of reactive oxygen species in isolated hepatocyte suspensions 2000 ·Chemico-Biological Interactions ·Mark A. Tirmenstein, (unknown), George Zhang, Marc W. Fariss	70
14	Administration of the TRIS salt of α-tocopheryl hemisuccinate inactivates CYP2E1, enhances microsomal α-tocopherol levels and protects against carbon tetrachloride-induced hepatotoxicity 1999 ·Free Radical Biology and Medicine ·Mark A. Tirmenstein, Xiaokang Ge, (unknown), Marc W. Fariss	20
15	A Fluorescence Plate Reader Assay for Monitoring the Susceptibility of Biological Samples to Lipid Peroxidation 1998 ·Analytical Biochemistry ·Mark A. Tirmenstein, Christopher Pierce, (unknown), Marc W. Fariss	25
16	Growth inhibition of MCF-7 and MCF-10A human breast cells by α-tocopheryl hemisuccinate, cholesteryl hemisuccinate and their ether analogs 1997 ·Cancer Letters ·Zora Djurić, Lance K. Heilbrun, Samir Lababidi, (unknown), Marc W. Fariss	48
17	Role of cellular thiol status in tocopheryl hemisuccinate cytoprotection against ethyl methanesulfonate-induced toxicity 1997 ·Biochemical Pharmacology ·Marc W. Fariss, (unknown), Mark A. Tirmenstein	14
18	Oxygen toxicity: Unique cytoprotective properties of vitamin E succinate in hepatocytes 1990 ·Free Radical Biology and Medicine ·Marc W. Fariss	62
19	α-tocopheryl succinate protects hepatocytes from chemical-induced toxicity under physiological calcium conditions 1989 ·Toxicology Letters ·Marc W. Fariss, (unknown), Todd M. O’Hara	32
20	High-performance liquid chromatography of thiols and disulfides: Dinitrophenol derivatives breakdown → 1987 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Marc W. Fariss, Donald J. Reed	484

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact